Classification
- Anatomical main groupMMusculo-skeletal system
- Therapeutic subgroupM03
- Pharmacological subgroupM03C
- Chemical subgroupM03CA
- Chemical substanceM03CA01Dantrolene
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 6 registrations
- Dantrium Capsules25 MG · Capsule · Knight Therapeutics INC.
- Dantrium Intravenous20 MG / VIAL · Powder For Solution · Knight Therapeutics INC.
- Dantrolene Sodium for Injection, USP20 MG / VIAL · Powder For Solution · Hikma Canada Limited
- Dantrium Cap 100MG100 MG · Capsule · Norwich Eaton Canada INC.
United States
FDA · 6 registrations
At a glance
- ATC code
- M03CA01
- ATC group
- Musculo-skeletal system
- Registers
- 8
- Registrations
- 23
- With their own page
- 20
- Companies
- 13
All medicines with Dantrolene
Human medicines from every register that match Dantrolene by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
23 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Dantrolene Sodium | United States | 100MG, 25MG, 50MG | capsule | Marketed | Elite Labs INC |
| Dantrolene Sodium | United States | 20MG/VIAL | injectable | Marketed | Eugia Pharma Speclts |
| Dantrolene Sodium for Injection, USP | Canada | 20 MG / VIAL | Powder For Solution | Marketed | Hikma Canada Limited |
| Dantrium | United States | 100MG, 25MG, 50MG | capsule | Marketed | PH Health |
| Dantrium | United States | 20MG/VIAL | injectable | Marketed | PH Health |
| DantrolenCombination | Brazil | Authorised | Cristália Produtos Químicos Farmacêuticos Ltda. | ||
| Revonto | United States | 20MG/VIAL | injectable | Marketed | Uswm |
| Ryanodex | United States | 250MG/VIAL | for suspension | Marketed | Eagle Pharms |
| Dantrium, capsules 25 mg | Netherlands | Capsule, hard | Authorised | Norgine B.V. | |
| Dantrium Capsules | Canada | 25 MG | Capsule | Marketed | Knight Therapeutics INC. |
| Dantrium Intravenous | Canada | 20 MG / VIAL | Powder For Solution | Marketed | Knight Therapeutics INC. |
| Dantrium | New Zealand | Cap 50 mg | Funded | ||
| Dantrium | New Zealand | Cap 25 mg | Funded | ||
| Dantrium IV | New Zealand | Inj 20 mg vial | Funded | ||
| Dantrium S29 | New Zealand | Cap 25 mg | Funded | ||
| Agilus | European Union | Authorised | Norgine B.V. | ||
| Agilus 120 MG Polvo Para Solucion Inyectable | Spain | 120 mg | polvo para solución inyectable | Marketed | Norgine B.V. |
| Agilus 120 mg poeder voor oplossing voor injectie | Netherlands | Poeder voor oplossing voor injectie | Authorised | Norgine B.V. | |
| Dantrium IV, poeder voor injectievloeistof 20 mg | Netherlands | Poeder voor oplossing voor injectie | Authorised | BModesto B.V. | |
| Agilus | Croatia | Authorised | |||
| Dantrium Cap 25MG | Canada | 25 MG | Capsule | Cancelled | Norwich Eaton Canada INC. |
| Dantrium Capsules | Canada | 100 MG | Capsule | Cancelled | Par Pharmaceutical Companies |
| Dantrium Cap 100MG | Canada | 100 MG | Capsule | Cancelled | Norwich Eaton Canada INC. |